Cited in:


This article has been cited by:

  1. 1
    C. Pouplard, C. Desconclois, F. Sobas, M. F. Aillaud, C. Ternisien, C. Caron, Does the presence of von Willebrand factor in FVIII-deficient plasma influences the measurement of FVIII inhibitor titres in haemophilia A patients?, International Journal of Laboratory Hematology, 2015, 37, 1
  2. 2
    Q. Shi, J. A. Schroeder, E. L. Kuether, R. R. Montgomery, The important role of von Willebrand factor in platelet-derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies, Journal of Thrombosis and Haemostasis, 2015, 13, 7
  3. 3
    M. I. Bravo, B. Da Rocha-Souto, S. Grancha, J. I. Jorquera, Native plasma-derived FVIII/VWF complex has lower sensitivity to FVIII inhibitors than the combination of isolated FVIII and VWF proteins. Impact on Bethesda assay titration of FVIII inhibitors, Haemophilia, 2014, 20, 6
  4. You have free access to this content4
    P. M. Mannucci, Q. Shi, S. Bonanad, R. Klamroth, Novel investigations on the protective role of the FVIII/VWF complex in inhibitor development, Haemophilia, 2014, 20,
  5. 5
    Massimo Franchini, Pier Mannuccio Mannucci, Hemophilia A in the third millennium, Blood Reviews, 2013, 27, 4, 179


  6. 6
    MARGARET V. RAGNI, von Willebrand factor: factor VIII protector and friend, Journal of Thrombosis and Haemostasis, 2012, 10, 11